Valuation : Becton, Dickinson and Company

Market Cap 51.11B 43.97B 41.26B 37.75B 70.46B 4,831B 71.02B 488B 190B 2,469B 192B 188B 7,951B P/E 2026 *
36.2x
P/E 2027 * 20.2x
Enterprise Value 66.99B 57.64B 54.09B 49.49B 92.36B 6,333B 93.1B 640B 249B 3,236B 252B 246B 10,423B EV / Sales 2026 *
3.47x
EV / Sales 2027 * 3.3x
Free-Float
73.18%
Yield 2026 *
2.09%
Yield 2027 * 2.13%
1 day-0.54%
1 week-1.54%
Current month-0.80%
1 month+9.69%
3 months+24.77%
6 months+8.82%
Current year-3.84%
1 week 184.05
Extreme 184.05
191.76
1 month 168.01
Extreme 168.01
193.07
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
278.45
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Compliance Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Date Insider Type Main position Quantity % Market Cap. Importance
8/26/26 Sell

Executive/Senior Manager

-165 0.0001%
8/20/26 Tax

Executive/Senior Manager

-1,049 0.0004%
8/13/26 Exercice

Chief Executive Officer

129,834 0.0471%
Change 5-day change 1-year change 3-year change Capi.($)
-0.49%-1.54%-2.43%-31.61% 51.11B
+0.84%-2.46%-17.40%+8.75% 188B
+1.26%+3.24%+1.44%+17.44% 119B
-0.89%+3.77%+14.17%+93.31% 64.35B
-1.31%-1.33%+23.64%+48.69% 52.59B
-1.71%-2.92%+9.18%-12.12% 33.85B
+0.74%+4.29% - - 32.1B
-0.36%+1.22%+37.99%-15.38% 24.12B
-1.44%-5.00%-7.60%+9.97% 23.39B
-0.45%-3.82%-7.62%+0.54% 22.12B
Average -0.40%-0.18%+5.71%+13.29% 61.1B
Weighted average by Cap. +0.09%-0.65%-0.33%+17.51%

Financials

2026 *2027 *
Net sales 19.29B 16.6B 15.58B 14.25B 26.6B 1,824B 26.81B 184B 71.76B 932B 72.44B 70.86B 3,001B 19.73B 16.98B 15.93B 14.58B 27.21B 1,865B 27.42B 188B 73.4B 953B 74.1B 72.48B 3,070B
Net income 1.44B 1.24B 1.16B 1.06B 1.98B 136B 2B 13.72B 5.34B 69.4B 5.39B 5.28B 224B 2.34B 2.01B 1.89B 1.73B 3.23B 221B 3.25B 22.35B 8.7B 113B 8.79B 8.59B 364B
Net Debt 15.88B 13.67B 12.83B 11.73B 21.9B 1,502B 22.08B 152B 59.09B 767B 59.65B 58.35B 2,471B 13.95B 12B 11.26B 10.31B 19.24B 1,319B 19.39B 133B 51.9B 674B 52.39B 51.25B 2,171B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26-09-04 $186.15 -0.78% 448,751
26-09-03 $187.62 +0.05% 1,206,509
26-09-02 $187.52 +0.21% 1,474,463
26-09-01 $187.12 -0.53% 1,279,742
26-08-31 $188.11 -0.74% 2,629,617
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
187.62USD
Average target price
195.67USD
Spread / Average Target
+4.29%

Quarterly revenue - Rate of surprise